Yu-xi Yan

(5R)-5-hydroxytriptolide ameliorates anti-glomerular basement membrane glomerulonephritis in NZW mice by regulating Fcγ receptor signaling

Heng Li, Jian-Ping Zuo, Ze-min Lin, 2017, Acta Pharmacologica Sinica.

RIPK1 inhibitor ameliorates colitis by directly maintaining intestinal barrier homeostasis and regulating following IECs-Immuno crosstalk.

Heng Li, Jian-Ping Zuo, Wei Tang, 2019, Biochemical pharmacology.

Topical administration of reversible SAHH inhibitor ameliorates imiquimod‐induced psoriasis‐like skin lesions in mice via suppression of TNF‐&agr;/IFN‐&ggr;‐induced inflammatory response in keratinocytes and T cell‐derived IL‐17

Heng Li, Jian-Ping Zuo, Wei Tang, 2017, Pharmacological research.

Artemisinin analog SM934 alleviates epithelial barrier dysfunction via inhibiting apoptosis and caspase-1-mediated pyroptosis in experimental colitis

Jian-Ping Zuo, Xiaoqian Yang, Feng-hua Zhu, 2022, Frontiers in Pharmacology.

(5R)-5-hydroxytriptolide ameliorates lupus nephritis in MRL/lpr mice by preventing infiltration of immune cells.

Wei Tang, Heng Li, Jian-Ping Zuo, 2017, American journal of physiology. Renal physiology.

Artemisinin analogue SM934 ameliorates DSS-induced mouse ulcerative colitis via suppressing neutrophils and macrophages

Heng Li, Jian-Ping Zuo, Feng-hua Zhu, 2018, Acta Pharmacologica Sinica.